H. Sälzer

1.2k total citations
56 papers, 892 citations indexed

About

H. Sälzer is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, H. Sälzer has authored 56 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Reproductive Medicine, 9 papers in Obstetrics and Gynecology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in H. Sälzer's work include Ovarian cancer diagnosis and treatment (22 papers), Metabolism and Genetic Disorders (7 papers) and Estrogen and related hormone effects (6 papers). H. Sälzer is often cited by papers focused on Ovarian cancer diagnosis and treatment (22 papers), Metabolism and Genetic Disorders (7 papers) and Estrogen and related hormone effects (6 papers). H. Sälzer collaborates with scholars based in Austria, Germany and United Kingdom. H. Sälzer's co-authors include Ayman Tammaa, Gernot Hudelist, N Fritzer, A. Thomas, Dietmar Haas, Christiane Niehues, Peter Oppelt, P. Sevelda, Z. Yaron and Guido Strunk and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

H. Sälzer

52 papers receiving 858 citations

Peers

H. Sälzer
H. Sälzer
Citations per year, relative to H. Sälzer H. Sälzer (= 1×) peers Nobuhiko Suganuma

Countries citing papers authored by H. Sälzer

Since Specialization
Citations

This map shows the geographic impact of H. Sälzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Sälzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Sälzer more than expected).

Fields of papers citing papers by H. Sälzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Sälzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Sälzer. The network helps show where H. Sälzer may publish in the future.

Co-authorship network of co-authors of H. Sälzer

This figure shows the co-authorship network connecting the top 25 collaborators of H. Sälzer. A scholar is included among the top collaborators of H. Sälzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Sälzer. H. Sälzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vogel, Georg F., Dietmar Rieder, H. Sälzer, et al.. (2024). Kinesin family member 12 ‐related hepatopathy: A generally indolent disorder with elevated gamma‐glutamyl‐transferase activity. Clinical Genetics. 106(3). 224–233.
2.
Tammaa, Ayman, et al.. (2015). Interobserver agreement and accuracy of non‐invasive diagnosis of endometriosis by transvaginal sonography. Ultrasound in Obstetrics and Gynecology. 46(6). 737–740. 42 indexed citations
3.
Fritzer, N, Ayman Tammaa, H. Sälzer, & Gernot Hudelist. (2013). Dyspareunia and quality of sex life after surgical excision of endometriosis: a systematic review. European Journal of Obstetrics & Gynecology and Reproductive Biology. 173. 1–6. 36 indexed citations
4.
Lohninger, Alfred, et al.. (2009). Relationship between Carnitine, Fatty Acids and Insulin Resistance. Gyn�kologisch-geburtshilfliche Rundschau. 49(4). 230–235. 7 indexed citations
5.
Lohninger, Alfred, Heidrun Karlic, Ayman Tammaa, et al.. (2005). Carnitine in Pregnancy. Monatshefte für Chemie - Chemical Monthly. 136(8). 1523–1533. 2 indexed citations
6.
Mirzaei, Siroos, Brigitte Hoffmann, Peter Knoll, et al.. (2003). Sentinel lymph node detection with large human serum albumin colloid particles in breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 30(6). 874–878. 19 indexed citations
7.
Ulrich, U., Kerstin Rhiem, J. Schmolling, et al.. (2001). Cross-linked type I collagen C- and N-telopeptides in women with bone metastases from breast cancer. Archives of Gynecology and Obstetrics. 264(4). 186–190. 30 indexed citations
8.
Mirzaei, Siroos, et al.. (2000). Scintimammography enhances negative predictive value of non-invasive pre-operative assessment of breast lesions. European Journal of Surgical Oncology. 26(8). 738–741. 2 indexed citations
9.
Winter, R., Hans Concin, Lothar C. Fuith, et al.. (1997). Leitlinien für die operative Behandlung des Zervixkarzinoms erstellt von der Standardkommission der Osterreichischen Gesellschaft für Gynäkologie und Geburtshilfe. Gyn�kologisch-geburtshilfliche Rundschau. 37(4). 227–229. 2 indexed citations
10.
Sälzer, H., et al.. (1996). [Animal experiment and clinical studies of the significance of carnitine for energy metabolism in pregnant patients and the fetus during the pre- and perinatal period].. PubMed. 108(2). 33–9. 6 indexed citations
11.
Rosén, Anders, P. Sevelda, Michael Klein, et al.. (1993). First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer. British Journal of Cancer. 67(5). 1122–1125. 25 indexed citations
12.
Vavra, N., H. Kucera, Ursula Denison, et al.. (1992). Nicotine Abuse as a Prognostic Factor in Stage Ib Cervical Carcinoma. Oncology Research and Treatment. 15(4). 295–299. 1 indexed citations
13.
Dittrich, Christian, P. Sevelda, Marcus Hudec, et al.. (1991). Clonogenic growth in vitro: an independent biologic prognostic factor in ovarian carcinoma.. Journal of Clinical Oncology. 9(3). 381–388. 18 indexed citations
14.
Pateisky, N., et al.. (1991). Ferritinspiegel von Neugeborenen nach präpartaler Eisenmedikation. Geburtshilfe und Frauenheilkunde. 51(5). 366–368. 9 indexed citations
15.
Sevelda, P., et al.. (1990). Ist die Verlaufskontrolle falsch negativer CA-125 Serumwerte in der Tumornachsorge des Ovarialkarzinoms sinnvoll?. Gyn�kologisch-geburtshilfliche Rundschau. 30(1). 210–211. 2 indexed citations
16.
Wrba, Friedrich, Marcus Hudec, Thomas W. Grunt, et al.. (1990). Analysis of factors influencing clonogenic growth in vitro of cells from ovarian carcinoma patients. Cancer Letters. 50(3). 183–189. 8 indexed citations
17.
Sevelda, P., et al.. (1989). The value of second-look operation in patients with advanced epithelial ovarian carcinoma. Archives of Gynecology and Obstetrics. 244(2). 79–86. 5 indexed citations
18.
Slevin, ML, et al.. (1988). Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule. British Journal of Cancer. 57(1). 115–116. 29 indexed citations
19.
Zielinski, C. C., E. Kubista, H. Sälzer, et al.. (1987). Der Einfluß von Hormonrezeptoren auf die Metastasenlokalisation beim Mammakarzinom. Oncology Research and Treatment. 10(5). 302–303. 1 indexed citations
20.
Sälzer, H., et al.. (1983). Estrogen – and Gestagen – Receptors in Ovarian Carcinoma. Gynecologic and Obstetric Investigation. 16(4). 189–198. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026